Hospira

Hospira, Inc. Q2 2008 Earnings Call Transcript

Seeking Alpha (Free subscription) | 20 hours ago

Hospira, Inc. (HSP) Q2 FY08 Earnings Call Complete Story »

Hospira profit doubles, but short of expectations

Chicago Tribune (Free subscription) | yesterday

Hospira Inc.'s second-quarter net income more than doubled on surging margins as the company's acquisition last year of Mayne Pharma helped drive growth in its injectable-pharmaceuticals business.

Hospira's quarterly profit more than doubles

Market Watch (Free subscription) | yesterday

NEW YORK (MarketWatch) -- Hospira Inc. said Wednesday that its second-quarter profit more than doubled to $69.1 million, or 43 cents a share, from $30.7 million, or 20 cents a share, in the year-ago period. Adjusted earnings rose to 57 cents a share from 49 cents a share. Net sales rose 3.7% to $901.6 million from $869.3 million. Analysts surveyed by FactSet Research forecast earnings of 62 cents...

Hospira Reports Second-Quarter 2008 Results

PR News Wire (Free subscription) | yesterday

Hospira Wins Dismissal But Loses Time

Patent Appeal Tracer (Free subscription) | yesterday

2008-1499 Aventis Pharma v. Hospira CD/CA 07-CV-8137 Judge Mariana R. Pfaelzer Aventis has appealed from Judge Pfaelzer's Order granting Hospira's motion for judgment on the pleadings and dismissing Aventis's infringement claim with prejudice based on collateral estoppel. Aventis owns U.S....

Hospitals and Healthcare Providers to Save With Premier Invasive Hemodynamic Monitoring Products Agreements

Red Orbit (Free subscription) | 07/23/2008

Premier Purchasing Partners, LP, today announced new agreements for invasive hemodynamic monitoring products and accessories have been awarded to Edwards Lifesciences LLC of Irvine, Calif.; Hospira Worldwide Inc. of Lake Forest, Ill.; and Pulsion Medical Inc.

Abbott to face trial on Hospira separation

Chicago Tribune (Free subscription) | 07/15/2008

Workers claim deception on post-spinoff benefits Abbott Laboratories, the fourth-biggest U.S. drugmaker, must face a trial on claims it deceived workers who joined its Hospira Inc. spinoff about whether their benefits would be cut after they did so.

Federal Judge Denies Abbott Labs´ and Hospira, Inc.´s Motions for Summary Judgment, Allowing ERISA..

EuroInvestor.co.uk (Free subscription) | 07/15/2008

Federal District Court Judge Robert W. Gettleman denied motions for summary judgment filed by Abbott Laboratories and Hospira, Inc. removing the plaintiffs ’ l.. - Read more

Cramer's 'Mad Money' Recap: Stick With Generic Injectable Drugs

The Street (Free subscription) | 07/11/2008

Cramer thinks highly of Hospira, which makes generic drugs that are ready to use in disposable syringes.

Cramer's 'Mad Money' Recap: July 10

The Street (Free subscription) | 07/11/2008

Cramer thinks highly of Hospira, which makes generic drugs that are ready to use in disposable syringes.

Hospira Hosts Conference Call for Second-Quarter 2008 Earnings

PR News Wire (Free subscription) | 07/07/2008

LAKE FOREST, Ill., July 7 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: ), a global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its second-quarter 2008 results on Wednesday, Aug. 6, 2008, at 8 a.m. Central time. The company will release its second-quarter results earlier that morning, before the U.S. stock market open and...

Altea, Hospira To Develop Transdermal Product

Contract Pharma Breaking News (Free subscription) | 07/02/2008

Altea Therapeutics has entered into a partnership with Hospira for the development and commercialization of an undisclosed product using its PassPort Transdermal Delivery System. Under the terms of the agreement, Hospira has exclusive worldwide rights to develop and commercialize the product. Altea will fund certain Phase I studies and Hospira will fund all further product development, manufacturing,...

• Altea Therapeutics and Hospira Enter into Development and Commercialization Agreement for Transdermal Product - Red Orbit
• Altea Therapeutics and Hospira enter into Development and Commercialization Agreement for Transdermal Product - Business Wire

Barbara Bowles Named to Hospira Board

News On Women (Free subscription) | 05/14/2008

Hospira Inc. (NYSE: HSP), headquartered in Illinois, appointed Barbara Bowles to its Board of Directors. Barbara recently retired as Vice Chair of Profit Investment Management. Read more about Barbara's career in the prnewswire press release.

Hospira Expands Board of Directors

PR News Wire (Free subscription) | 05/13/2008

LAKE FOREST, Ill., May 13 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: ), a global specialty pharmaceutical and medication delivery company, announced today that Barbara L. Bowles, CFA, has been elected to the company's board of directors. Bowles brings strong investment management and finance expertise from leadership positions held at major multinational consumer goods companies and equity investment...

Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders

PR News Wire (Free subscription) | 05/13/2008

- Shareholders Ratify Both Proposals - LAKE FOREST, Ill., May 13 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: ), a leading global specialty pharmaceutical and medication delivery company, today held its 2008 Annual Meeting of Shareholders in Wilmington, Del. The agenda included votes on two proposals and a brief update on the company's progress and strategy. "Our 2007 results point to the success...